Get news updates from AACRMeetingNews.org
Subscribe below to get email updates from AACRMeetingNews.org
-
Symposium explores role of radiomics, AI analysis in cancer imaging
(From left) Maryellen L. Giger, PhD, Eugene Jon Koay, MD, PhD, and Robert J. Gillies, PhD, also took part in a panel discussion during the AACR Annual Meeting 2021.
-
Session highlights transcriptional CDKs as cancer target
The presentation featured (from left) Ricky W. Johnstone, PhD, Rani George, MD, PhD, and Ali Shilatifard, PhD.
-
Session examines mechanisms and myths of radiation-induced cancer
(From left) Jean L. Nakamura, MD, and Jason Harris, PhD, gave presentations and participated in a panel discussion.
-
Symposium discusses precision medicine approaches for familial cancers
(From left) Yael P. Mossé, MD, Susan M. Domchek, MD, Uri Tabori, MD, David Malkin, MD, spoke during the symposium and related panel discussion.
-
Symposium focuses on novel genomic approaches to studying diffuse large B-cell lymphoma
(From left) Ari Melnick, MD, Margaret A. Shipp, MD, and Michael R. Green, PhD, shared their findings during their presentation.
-
National Cancer Institute director details bridge to the future of cancer care
Norman E. Sharpless, MD, told AACR Annual Meeting 2021 attendees that this is the golden age of cancer care, but many of the biggest challenges still remain.
-
Session focuses on molecular approaches to precision prevention of cancer
Presenters (clockwise, from top left) Adriana Albini, PhD, Andrew J. Dannenberg, MD, Victoria Seewaldt, MD, and Cory Abate-Shen, PhD, also participated in a panel.
-
Panelists explore diagnostic approaches, replication stress, and resistance mechanisms to DDR-targeting therapies
The session and related panel discussion featured (from left) Joaquin Mateo, MD, PhD, Mark J. O’Connor, PhD, and Fiona Simpkins, MD.
-
New approaches exploit cell plasticity to reduce resistance to cancer therapies
(From left) Owen N. Witte, MD, Mark A. Rubin, PhD, and Paul Smith, BSc, PhD, were the presenters in this session.
-
Symposium examines intricacies of the premetastatic niche
(From left) David Lyden, MD, PhD, Dihua Yu, MD, PhD, and Xuetao Cao, MD, PhD, shared insights from their research in this area.